Literature DB >> 4006652

Variation in morphine pharmacokinetics in children with cancer.

M C Nahata, A W Miser, J S Miser, R H Reuning.   

Abstract

Morphine plasma concentrations were determined in 19 children with cancer. A single dose of morphine, 0.09-0.15 mg/kg, was given intravenously over 3-5 min. The plasma concentrations of morphine ranged from 23 to 472 ng/ml at 10 min and from 6.1 to 20.8 ng/ml at 60 min after morphine administration. The morphine plasma concentration exceeded the reported average analgesic concentration of about 20 ng/ml in only 1 patient at 60 min and subsequently declined further except for 4 patients in whom plasma levels exhibited a secondary peak. The pharmacokinetics of morphine was studied in 6 children. The total clearance of morphine ranged from 9.03 to 53.4 ml/min/kg. The apparent volume of the central compartment and the apparent volume of distribution at steady state ranged from 0.17 to 1.10 and from 2.06 to 7.86 l/kg, respectively. The elimination half-life ranged from 0.86 to 7.55 h. These data indicate that an interindividual variation in morphine pharmacokinetics is one factor responsible for varying dosage requirements in children with cancer.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4006652     DOI: 10.1159/000457035

Source DB:  PubMed          Journal:  Dev Pharmacol Ther        ISSN: 0379-8305


  7 in total

1.  Morphine and morphine-6-glucuronide in the plasma and cerebrospinal fluid of children.

Authors:  R D Hain; A Hardcastle; C R Pinkerton; G W Aherne
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

2.  Morphine metabolism in children.

Authors:  I A Choonara; P McKay; R Hain; A Rane
Journal:  Br J Clin Pharmacol       Date:  1989-11       Impact factor: 4.335

Review 3.  Clinical pharmacokinetics and pharmacodynamics of opioid analgesics in infants and children.

Authors:  K T Olkkola; K Hamunen; E L Maunuksela
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

4.  Morphine kinetics after diamorphine infusion in premature neonates.

Authors:  D A Barrett; A C Elias-Jones; N Rutter; P N Shaw; S S Davis
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

5.  Morphine glucuronidation in premature neonates.

Authors:  R Hartley; M Quinn; M Green; M I Levene
Journal:  Br J Clin Pharmacol       Date:  1993-03       Impact factor: 4.335

6.  Pharmacokinetics of Morphine and Its Metabolites in Infants and Young Children After Congenital Heart Surgery.

Authors:  Mohammed H Elkomy; David R Drover; Kristi L Glotzbach; Jeffery L Galinkin; Adam Frymoyer; Felice Su; Gregory B Hammer
Journal:  AAPS J       Date:  2015-09-09       Impact factor: 4.009

Review 7.  Inter-individual variation in morphine clearance in children.

Authors:  Mohammed I Altamimi; Imti Choonara; Helen Sammons
Journal:  Eur J Clin Pharmacol       Date:  2015-04-08       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.